Pfizer Has Agreed to Pay $345 Million to Resolve Claims by Consumers Who Claim They ... - Latest Tweet by Reuters

Pfizer has agreed to pay $345 million to resolve claims by consumers who claim they overpaid for EpiPens due to anticompetitive practices by the drugmaker and Mylan, the company that markets the emergency allergy treatment https://t.co/53ZZibez2O pic.twitter.com/FH666adRSg— Reuters (@Reuters) July 16, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)